IN-VIVO GENE-THERAPY OF HUMAN LUNG-CANCER USING WILD-TYPE P53 DELIVERED BY RETROVIRUS

被引：23

作者：

CARBONE, DP

MINNA, JD

机构：

来源：

关键词：

D O I：

10.1093/jnci/86.19.1437

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1437 / 1438

页数：2

共 12 条

[1] P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES
CAELLES, C
HELMBERG, A
KARIN, M
[J]. NATURE, 1994, 370 (6486) : 220 - 223
[2] CARBONE DP, 1992, ADV INTERNAL MED, V37, P153
[3] CHEN JY, 1993, ONCOGENE, V8, P2159
[4] CHIBA I, 1990, ONCOGENE, V5, P1603
[5] DAMICO D, 1992, ONCOGENE, V7, P339
[6] FREEMAN SM, 1993, CANCER RES, V53, P5274
[7] FUJIWARA T, 1993, CANCER RES, V53, P4129
[8] THERAPEUTIC EFFECT OF A RETROVIRAL WILD-TYPE P53 EXPRESSION VECTOR IN AN ORTHOTOPIC LUNG-CANCER MODEL
FUJIWARA, T
CAI, DW
GEORGES, RN
MUKHOPADHYAY, T
GRIMM, EA
ROTH, JA
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (19) : 1458 - 1462
[9] A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA
KASTAN, MB
ZHAN, QM
ELDEIRY, WS
CARRIER, F
JACKS, T
WALSH, WV
PLUNKETT, BS
VOGELSTEIN, B
FORNACE, AJ
[J]. CELL, 1992, 71 (04) : 587 - 597
[10] Minna JD, 1989, CANCER PRINCIPLES PR, P591